High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis

BACKGROUND: Immunotherapy has become the standard of care for non-small cell lung cancer (NSCLC) patients. Some patients experience primary resistance to immunotherapy. Currently, we lack a marker of resistance to immunotherapy. Myeloid-derived suppressive-like cells (MDSCs) can reduce tumor respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Bronte, Giuseppe, Petracci, Elisabetta, De Matteis, Serena, Canale, Matteo, Zampiva, Ilaria, Priano, Ilaria, Cravero, Paola, Andrikou, Kalliopi, Burgio, Marco Angelo, Ulivi, Paola, Delmonte, Angelo, Crinò, Lucio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043492/
https://www.ncbi.nlm.nih.gov/pubmed/35493483
http://dx.doi.org/10.3389/fimmu.2022.866561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043492/
https://www.ncbi.nlm.nih.gov/pubmed/35493483
http://dx.doi.org/10.3389/fimmu.2022.866561

Ejemplares similares